The Effectiveness of a Protocol for Muscular Foot Strengthening On a Capacity to Control the Deformation of the DOT Plantar Medial

A Protocol for Muscular Foot Strengthening On a Capacity to Control the Deformation of the DOT Plantar Medial

The human foot allows to perform several functions, rather than providing a Static support for the body, the foot acts dynamically in walking and Movement of the body, requiring adequate biomechanics responsible for Maintenance and posture of the body and harmonic distribution of plantar pressure.

One of the most important structures for this control is the medial plantar vault (MPA), an important structure in the absorption of impact and essential for the function Foot. The deformation of the MPA in the gait support phase absorbs the Energy and propels the limb, to perform this biomechanical function the MPA must Stable from the anatomical point of view, which is conferred by the bone architecture and But also by the performance of the intrinsic and extrinsic musculature of the Feet. The fall of the MPA, decreases the stability of the foot, limits its biomechanical function,

Besides being a risk factor for the development of pathologies such as:

Tendinopathy of the calcaneus tendon and plantar fasciitis. Various Intrinsic Muscles And extrinsic have the function of stabilizing the foot and the MPA, being the main Extrinsic muscles: the posterior tibial, the flexor long of the hallux and the fingers. The Muscles when activated increase the height and decrease the Length of the MPA. Several methods are used to evaluate ALM, such as (AN), Feiss line (LF) and MPA angle (MPAH), in addition to the Baropodometry, which is used to evaluate dysfunctions in the feet, with the principle of Map the pressure of the plantar surface in a static and dynamic way. Based In this information, this study aims to evaluate the influence of the Strengthening of the intrinsic and extrinsic muscles of the feet, for the Of MPA in asymptomatic patients.

Study Overview

• Status: Completed
• Conditions: Foot Diseases
• Intervention / Treatment: Other: Exercise for Foot Strengthening; Other: Exercise for Foot Strengthening and Electrostimulation

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Brazil
  • São Paulo
    • Sao Paulo, São Paulo, Brazil, 03156001
      • Claudio Cazarini Júnior

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Individuals between the ages of 18 and 40,
• Seeders (do not practice physical activity regularly)
• No previous injuries to the feet and ankles,
• 12 months without lesions in lower members,
• Without deformities in APM,
• Such as, rigid planar foot
• No history of neurological changes

Exclusion Criteria:

• Individuals who practice physical activities regularly,
• History of pain in the feet,
• Have suffered fractures in the lower limbs,
• Muscular and articular lesions of Lower members in 12 months, -
• Flat foot,
• Valgus of calcaneus above 10º
• History of neurological changes or surgical procedure performed on lower limbs

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control Group
Experimental: Exercise Group	Other: Exercise for Foot Strengthening; Stabilization exercises of the longitudinal arch of the foot
Active Comparator: Exercise and NMES Group	Other: Exercise for Foot Strengthening and Electrostimulation; Exercise for the Strengthening of the Foot associated with Electrostimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Measurements of the medial longitudinal arch	Navicular height Angle of the medial longitudinal arch Feiss line	6 weeks

Collaborators and Investigators

• Sponsor: Faculdade de Ciências Médicas da Santa Casa de São Paulo

Study record dates

Study Major Dates

• Study Start (Actual): December 12, 2016
• Primary Completion (Actual): January 2, 2018
• Study Completion (Actual): April 10, 2019

Study Registration Dates

• First Submitted: April 10, 2017
• First Submitted That Met QC Criteria: April 12, 2017
• First Posted (Actual): April 17, 2017

Study Record Updates

• Last Update Posted (Actual): April 25, 2019
• Last Update Submitted That Met QC Criteria: April 24, 2019
• Last Verified: April 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Skin Diseases; Musculoskeletal Diseases; Foot Diseases
• Other Study ID Numbers: 62766716.4.0000.5479

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No